Business Context and Reporting Period
Company: DaVita Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: October 31, 2005
Reporting Period: This filing announces financial results for the quarter and nine months ended September 30, 2005. The report serves as a vehicle to disseminate a press release (Exhibit 99.1) containing these results.
Key Financial Metrics
The Form 8-K text itself does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These figures are contained within the attached press release (Exhibit 99.1), which is referenced but not included in the provided text.
Non-GAAP Measures Discussed: The filing details the use of several non-GAAP financial measures to supplement GAAP results, including:
- Net income excluding Medicare lab recoveries related to prior years' services, swap valuations, and refinance charges.
- Operating income excluding Medicare lab recoveries related to prior years' services.
- Operating cash flows and free cash flows excluding Medicare lab recoveries and tax benefits from stock option exercises.
- Consolidated EBITDA (as defined in senior notes indentures) for debt leverage ratio calculations.
- Operating revenue excluding Medicare lab recoveries related to prior years' services.
Material Changes
The filing text does not provide specific data on material changes versus prior periods. It notes that the company historically reports non-GAAP measures to exclude non-recurring expenses and Medicare lab recoveries that cause unusual fluctuations, aiming to provide consistency and comparability to prior periods.
Guidance, Outlook, and Risks
Forward-Looking Statements: The attached press release contains forward-looking statements regarding performance for 2005 and 2006. The company states these are based on currently available information and involve substantial known and unknown risks.
Risks and Uncertainties: Actual results could differ materially from those described due to risks and uncertainties. The company explicitly disclaims any obligation to update or revise these forward-looking statements.
Unusual Items: The filing highlights that Medicare lab recoveries related to prior years' services, swap valuations, and refinance charges are treated as unusual items that are excluded from certain non-GAAP measures to better reflect normal operating results.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for specific GAAP and non-GAAP financial figures for the quarter and nine months ended September 30, 2005.
- Verify the reconciliation tables in the press release that bridge non-GAAP measures to the most directly comparable GAAP measures.
- Examine the specific forward-looking guidance for 2005 and 2006 provided in the press release.
- Confirm the impact of Medicare lab recoveries and swap valuations on the reported net income and operating income.
- Check the debt leverage ratio calculation based on consolidated EBITDA as defined in the senior notes indentures.